Navigation Links
Cordex Pharma Sets Fourth Quarter 2008 Program Update Call
Date:2/13/2009

Conference call scheduled for Friday, February 20, at 10:00 a.m. EST

LA JOLLA, Calif., Feb. 13 /PRNewswire-FirstCall/ -- Cordex Pharma, Inc. (OTC Bulletin Board: CDXP) will host a teleconference on Friday, February 20, at 10:00 a.m. EST to provide a fourth quarter business review and drug development update. Cordex's Chief Executive Officer, James S. Kuo, M.D., M.B.A., will give the presentation and there will be a question-and-answer session immediately afterwards.

To participate in the teleconference, please call toll-free 800.894.5910 (direct dial 785.424.1052) five minutes prior to the scheduled starting time in order to register for the call.

A replay of the call will be available after the call's completion for ten days at 800.283.8520 (direct dial 402.220.0870).

About Cordex Pharma, Inc.

Cordex is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex has a portfolio of investigational medicines, two of which are in late stages of clinical development. Cordex's ATPace is expected to enter a Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia in 2009. Cordex's CDP-1050 is also expected to commence a Phase 2 clinical trial for the treatment of heart failure in 2009. In addition, Cordex has a preclinical program to develop new chemical entities that target a recently discovered pathway in the pathophysiology of chronic obstructive pulmonary disease. For further information regarding Cordex, please visit the company's website at www.cordexpharma.com.

Forw
'/>"/>

SOURCE Cordex Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Combination Products Executive Forum to be Hosted by CHI's Pharmaceutical Strategy Series
2. Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2008 Financial Results Teleconference and Webcast
3. Union Springs Pharmaceuticals Introduces New, More Effective Respirator
4. URAC Calls for Public Comment on Revisions to its Pharmacy Benefit Management (PBM) and Drug Therapy Management (DTM), Version 2.0 Standards and NEW Performance Measures, and PHARM Core, Version 3.0 Standards
5. Shengtai Pharmaceutical Schedules 2009 Second Quarter Financial Results and Conference Call
6. ISTA Pharmaceuticals Announces Conference Call and Webcast of Fourth Quarter and Full-Year 2008 Financial Results
7. Managing Myeloma (www.managingmyeloma.com) Launches - A Comprehensive Information and Educational Site for Physicians, Nurse Practitioners, Physician Assistants, and Pharmacists
8. Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer
9. DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease
10. Portola Pharmaceuticals Enters Worldwide License Agreement for Development and Commercialization of Novel Antiplatelet Drug Elinogrel
11. Valeant Pharmaceuticals to Announce 2008 Fourth Quarter and Year Results on February 24, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... say they have used human embryonic stem cells to ... While this had already been done using rodent stem ... of cells -- called primordial germ cells -- have ... the team at the University of Cambridge in England. ... of the earliest events during early mammalian development," study ...
(Date:12/24/2014)... 2014 (HealthDay News) -- A lab technician with the ... been exposed to the Ebola virus in an agency ... to a dozen other lab workers are being checked ... The possible exposure occurred Monday when CDC scientists ... the potentially lethal virus to another CDC lab in ...
(Date:12/24/2014)... 2014 Gluten, a protein found predominately ... have an intolerance to gluten, causing side effects that ... headaches, joint pain and fatigue. For this reason, Diet ... that deliver safe and fast weight loss while teaching ... gluten allergy reaction. These gluten free diet plans combine ...
(Date:12/24/2014)... Florida (PRWEB) December 24, 2014 The Healthy ... safer place to raise families. In-Vest USA ... who protect us – our first responders. Today, these two ... enforcement officers by providing them with body armor through In-Vest’s ... the tragic shootings that happened this past week in New ...
(Date:12/24/2014)... Texas (PRWEB) December 24, 2014 ... Industry is a professional and in-depth research report ... report introduces COC basic information, including its definition, ... analysis, news analysis, etc. This report also presents ... etc. Production is separated by regions, technology and ...
Breaking Medicine News(10 mins):Health News:CDC Monitors Lab Worker for Possible Ebola Exposure 2Health News:Diet Doc Adds Gluten Free Diet Plans to Their Stable of Specialized Weight Loss Programs 2Health News:Diet Doc Adds Gluten Free Diet Plans to Their Stable of Specialized Weight Loss Programs 3Health News:The Healthy Home Company and In-Vest USA Team Up to Save the Lives of Law Enforcement 2Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 2Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 3
... it has launched the authorized generic version of Merck's Proscar ... ,The company has also launched the authorized generic version of ... 40 mg and 80 mg yesterday, a company release said. ... separate agreements with Merck that enabled it to launch the ...
... women-only Fatima Jinnah University in Rawalpindi is embroiled in ... ,Opposition members in the National Assembly protested ... sister of Mohammad Ali Jinnah, the founder of Pakistan. ... Daily Times that a portion of the campus had ...
... the All India Institute of Medical Sciences (AIIMS) is contemplating ... //by "some colleagues and misguided students". ,"The day ... post of vice-chancellor of K.G. Medical University in Lucknow. I ... the prevalent situation (in AIIMS)," said R.C. Deka, a leading ...
... heart transplants are on the decline. This is because the ... doctors at the Papworth Hospital in Cambridge pioneered an operation ... after it was removed from the donor. The first patient ... Burt, 58, a builder from Burnham Market, Norfolk. ...
... given hopes that researchers will be able to re-establish ... humans challenged by deafness//. ,These tiny hairs in the ear ... the brain into sound. Once lost, these hairs could ... , ,Approximately, one out of every twenty-four people, across the ...
... by Canadian researchers show that the male survivors ... are not recognized and understood// many health care ... found that though both male and female childhood ... and fears about their encounters with health care ...
Cached Medicine News:Health News:'Humiliated' Dean Contemplates Leaving AIIMS 2Health News:'Humiliated' Dean Contemplates Leaving AIIMS 3Health News:Latest In the Heart Transplant Field 2Health News:Sexually Abused Males Found Struggling In heir relations with Healthcare Providers 2
(Date:12/24/2014)... 2014  Commonwealth Cornerstone Group (CCG) today announced the completion ... Tuesday to help fund the expansion and consolidation of healthcare ... Sharon . PHN is the largest ... . It is the largest employer in Sharon,s ... on staff. Currently, PHN Sharon offers scattered services ...
(Date:12/24/2014)...  The International Trade Commission (ITC) issued its final decision ... In a notice issued on December 23, the ITC ruled ... its humidifier was invalid. BMC President, James ... very excited with the ITC,s decision in this case. This ... since the very beginning on the key patents in the ...
(Date:12/24/2014)... YORK and LONDON , ... global orthopedic industry are expected to grow at an ... in terms of value and volume. Hip, knee and ... developed world while in emerging economies they have a ... rates are challenging the use of composites. Non-metallic orthopedic ...
Breaking Medicine Technology:Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 2Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 3ITC Final Decision Goes Against ResMed (RMD) Monumental Win for 3B/BMC 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3
... STAAR Surgical Company (NASDAQ: STAA ), a ... products, today reported financial results for the first quarter ... 8% to $14.8 million over the first quarter of ... and ICL) sales.  The Company achieved its first quarter ...
... 3, 2011 Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ) ... Total revenues for the quarter ended March ... the first quarter of 2010.  Total revenues included net product ... for the first quarter of 2011 was $21.8 million, or ...
Cached Medicine Technology:STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 2STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 3STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 4STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 5STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 6STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 7STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 8STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 9STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 10STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 11Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results 2Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results 3Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results 4Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results 5Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results 6Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results 7
... Tissue Sectioning System has maintained the reputation ... Researchers from around the globe have relied ... fresh and fresh fixed tissue sectioning needs ... the Vibratome Automatic Tissue Sectioning Systems, the ...
Replacement bulb for Vibratome light system....
Injector blades come ten to an injector and allow for the easy replacement of Vibratome cutting blades....
Vibratome Specimen Adhesive is a special formulation developed by a major adhesive manufacturer for applications such as tissue mounting. The advantage of this adhesive is that it has a strong holdi...
Medicine Products: